Skip to main content
. 2022 Mar 14;8(1):e12264. doi: 10.1002/trc2.12264

FIGURE 1.

FIGURE 1

Participant flow. [18F]FHBG PET/CT, 9‐(4‐[18F]fluoro‐3‐(hydroxymethyl)butyl) guanine positron emission tomography/computed tomography; 9‐CMMG, 9‐carboxymethoxymethylguanine; AD, Alzheimer's disease; APOE, apolipoprotein E; CSF, cerebrospinal fluid; HSV, herpes simplex virus; IgG, immunoglobulin G; MCI, mild cognitive impairment; NfL, neurofilament light chain; MMSE, Mini‐Mental State Examination; t‐tau, total tau.